Evidence map›Paper›PMID 40024741›Full record

ReviewInternal medicine (Tokyo, Japan)2025

Differences in Lung Cancer-related Clinical Practice and Basic Research Background between Japan and China: A Narrative Review.

Lan Wang, Yiyan Miao, Yihang Gu, Tomoya Kawaguchi, Megumi Mizutani, Toshiyuki Nakai, Tetsuya Watanabe, Kazuhisa Asai, Hui Zhang, Wenwen Cai and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lan WangDepartment of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Soochow University, China.
Yiyan MiaoThe Jiangyin Clinical College of Xuzhou Medical University, China.
Yihang GuDepartment of Geriatrics, The Jiangyin Clinical College of Xuzhou Medical University, China.
Tomoya KawaguchiDepartment of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Megumi MizutaniDepartment of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Toshiyuki NakaiDepartment of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Tetsuya WatanabeDepartment of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Kazuhisa AsaiDepartment of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Hui ZhangThe Jiangyin Clinical College of Xuzhou Medical University, China.
Wenwen CaiSanmen County People's Hospital, China.
Yoko TaniDepartment of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Hiroyasu KanedaDepartment of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With its increasing incidence, lung cancer has become one of the leading causes of cancer-related deaths worldwide, posing a great threat to the health and lives of patients. Due to varying economic and cultural backgrounds, there are significant differences in clinical treatment practices and related basic research on lung cancer between Japan and China. These differences are mainly reflected in many aspects, such as cancer prevention, cancer treatment, provision of medical insurance, patient compliance, medical education system, and sources of research funding. By understanding these differences, Japan and China can learn from each other, make progress together, and strengthen further exchanges and cooperation, which will help improve the long-term efficacy of lung cancer treatment and improve patients' clinical outcomes.

Indexed as

Biomedical ResearchLung NeoplasmsPractice Guidelines as TopicPractice Patterns, Physicians'ChinaHumansJapanbasic researchclinical practicehealth insurancelung cancerrisk factor

Identifiers

PMID40024741
PMCPMC12463414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.